Stem Cell Therapy Market Synopsis

Stem Cell Therapy Market Size Was Valued at USD 12.05 Billion in 2023, and is Projected to Reach USD 31.33 Billion by 2032, Growing at a CAGR of 11.20% From 2024-2032.

Stem cell therapy involves using stem cells to treat or prevent a disease or condition. Stem cells are unique because they have the potential to develop into many different types of cells in the body during early life and growth. In medical treatment, stem cells can be guided into becoming specific types of cells that can then be used to regenerate and repair diseased or damaged tissues in the body. This therapy holds promise for treating a wide range of conditions, from spinal cord injuries to diabetes, by harnessing the body's own regenerative capabilities.

• The stem cell therapy market is a rapidly growing subfield of the regenerative medicine industry, which holds the promise to transform many diseases’ treatments by utilizing the stem cells’ regenerative properties. These cells are characterized by high potential to develop into specialized cells of the human body and hold great potential in the treatment of diseases and injuries that may not have many solutions at the moment.

• Stem cell therapy market is growing globally due to the increasing research and development activities, increasing the incidence of chronic diseases and expanding uses across many medical fields. The market can be categorized based on stem cell types namely embryonic stem cells, induced pluripotent stem cells, and adult stem cells obtained from bone marrow, adipose tissue, and umbilical cord blood.

•  The developments in the methods of stem cell isolation, expansion and differentiation have been instrumental in the enhancement of the use of stem cells in the treatment of diseases. These have made it possible for the researchers and practitioners to come up with new therapies and interventions for ailments including cardiovascular diseases, neurodegenerative diseases, orthopedic injuries, and autoimmune diseases.

•  Thus, the stem cell therapy market, which has a great potential, has also met certain obstacles. The major challenge is the ethical and legal concerns regarding the use of embryonic stem cells where most of the countries have placed a ban or strict laws on the same. Also, the use of stem cell therapies is not without difficulties in terms of the safety and effectiveness of the treatment, which demands detailed clinical trials. 

•  However, issues such as scalability and standardization of the manufacturing processes still present major challenges to the commercialization of stem cell therapies. Such factors as the heterogeneity of cell quality and potency, as well as the requirements for the storage and transportation of the cells, complicate the market’s growth.

• Stem cell therapy market is expected to grow in the future due to increased funding in research, increasing collaboration between academic institutions and companies, and advancing pipeline of clinical trials. The increasing focus on the application of personalized medicine, as well as the advancement in cell-based cure present potential solutions to the unmet medical needs and better patient care.

•  Major companies in the market are investing their efforts in the research of new stem-cell based therapies and increasing their global presence through mergers and acquisitions. The markets in Asia-Pacific and Latin American region are also anticipated to provide a good growth prospect owing to the higher healthcare spending and improved awareness of regenerative medicine.

•  Thus, the stem cell therapy market has the promising opportunities to change the course of healthcare industry by providing the patients with the personalized and regenerative treatments despite of the existing issues of the regulation and technology. Further improvements in the field of science and the development of policies will help to increase the effectiveness of stem cells and bring new treatments to patients around the globe.

Stem Cell Therapy Market Trend Analysis

Growing Adoption in Regenerative Medicine

• The current market for regenerative medicine and stem cell therapy is rapidly expanding due to the increased research and development, enhanced biotechnological innovations, and the increasing rates of chronic diseases. Stem cell therapy, one of the branches of regenerative medicine, offers a possibility to treat numerous diseases by using stem cells to restore, replace or regenerate a variety of damaged cells, tissues and organs. This approach to treatment has attracted interest due to its possibility of use in managing ailments like heart diseases, nervous disorders, bone and joint injuries, and immunological diseases.

• The market growth is further backed by positive policy landscape in conducting clinical trials and commercialization of products as well as increased use of stem cells in the field of personalized medicine. Also, the collaboration with the pharmaceutical firms, biotechnological companies, and research organizations is bolstering the development and enhancing the potential of stem cell applications in the treatment. Nonetheless, the market for regenerative medicine and stem cell therapy is expected to grow from the existing restraints such as legal issues and ethical concerns due to the increased research and positive outcomes that will lead to new treatments and better patient results all over the world.

Expanding Applications in Neurological Disorders

• The stem cell therapy market is steadily growing especially in the use for neurological disorders. Stem cell therapies hold hope for treating diseases like Parkinson’s, Alzheimer’s, Spinal cord injuries, and stroke. These disorders are rather challenging as they are multifactorial and have little possibility of treatment. Stem cells which are capable of turning into completely different cell types offer a possibility of replacing the damaged neurons or supporting the regeneration of tissue in the nervous system. Presently, there are a number of continuing researches and clinical trials that are focusing on the various sources of stem cells namely the embryonic stem cells, the adult stem cells and the induced pluripotent stem cells that have their own opportunities and risks.

• The market also grows due to enhanced knowledge in biotechnology, genetic engineering and improved knowledge on the stem cell functions in the neurological conditions. Such approvals and rising investments in biopharmaceuticals reflect stakeholders’ escalating belief in stem cell therapies’ capabilities to revolutionise the treatment of neurological disorders and present patients with new opportunities for disease control and better quality of life.

Stem Cell Therapy Market Segment Analysis:

Stem Cell Therapy Market  Segmented based on  Therapy, Source, Application  and End User.

By  Therapy,  Autologous Cellular Immunotherapies segment is expected to dominate the market during the forecast period

• The main drivers of the stem cell therapy market are autologous cellular immunotherapies, autologous stem cell therapy, and other newly developed stem cell therapies. These therapies use the stem cells to cure many diseases and damages such as autoimmunity, bone and joint problems, and heart diseases. Cancer vaccines that are based on a patient’s own immune cells to attack and destroy cancer cells have proved to be effective in cancer treatment through boosting the immune system against tumours. Likewise, autologous stem cell therapy involves the use of a patient’s own stem cells to mend damaged tissues and organs, it also provide tailored treatment plans with minimal chance of rejection or attack by the body’s immune system.

•  It is a growth market due to rising research and development budgets, favorable legislations, and expanding use of regenerative medicine. Nevertheless, there are still issues like costly treatments, ethical questions, and the fact that clinical trials are quite complicated that still pose challenge to its usage. However, there are many potential obstacles to the growth of the stem cell therapy market, but it is expected that through the development of new technologies and research findings that the treatment will not only be more effective, but also more widely available in the future.

By Application , Bone Marrow  segment held the largest share in 2023

• The stem cell therapy market is diverse, with the stem cells obtained from a number of sources that includes bone marrow, epidermis, mesenchymal stem cells (MSCs) and other sources. The need for stem cells has increased because of their ability to be derived from bone marrow and due to their high ability to differentiate into various cell types thus useful in treating hematopoietic and musculoskeletal disorders. Epidermal stem cells located in the skin are involved in the processes of skin regeneration and repair, which makes their usage quite valuable in dermatology including wound healing and beauty treatments. Such cells include Mesenchymal stem cells that can be derived from bone marrow, adipose tissue, and umbilical cord blood and are regarded for their immunomodulatory capabilities which makes them useful in inflammatory and autoimmune diseases.

• Some of the other sources of stem cells include iPSCs and neural stem cells that also hold great potential in regenerative medicine due to their ability to form specialized cells for different organs and systems of the body as well as for neurological disorders. It is expected that the market will continue to grow due to the developments in the biotechnology, increase in number of clinical trials, and increase in usage across all therapeutic areas which portray that stem cells from different sources are useful for providing progressive treatment options and therapies.

Stem Cell Therapy Market  Regional Insights:

North America  is Expected to Dominate the Market Over the Forecast period

• North America is expected to lead the stem cell therapy market over the forecast period owing to a number of factors that are described below. First, the region has a highly developed system of healthcare and high investment in the sphere of biomedical researches and developments, thus promoting the development of regenerative medicine. Pharmaceutical and biotechnology bigwigs in the United States and Canada are participating in the clinical trials and commercial application of stem cell therapy, which is driving the market. Besides, favorable policies as well as growing government support for stem cell research adds to the growth of the market.

•  Also, the increasing rate of chronic diseases, for example, cancer, diabetes, and cardiovascular diseases in North America creates the need for advanced treatments including stem cell therapy to boost market growth. The availability of a favorable economic base, coupled with adequate funding in the healthcare and research sectors, enables leading players and new market entrants to increase the development of stem cell therapies, thus, strengthening North America’s position in the global stem cell therapy market over the forecast period.

Active Key Players in the Stem Cell Therapy Market 

• Athersys Inc. (U.S.)
• Mesoblast Ltd (Australia)
• Biorestorative Therapies Inc. (U.S.)
• Pluristem Inc. (Israel)
• Brainstorm Cell Limited. (U.S.)
• Viacyte Inc. (U.S.)
• Gamida Cell (U.S.)
• Hope Biosciences (U.S.)
• Cellular Biomedicine Group (U.S.)
• Smith+Nephew (U.K.)
• Medipost (South Korea)
• Anterogen. C.O., Ltd. (South Korea)
• Nuvasive Inc. (U.S.)
• Rti Surgical (U.S.)
• Allosource (U.S.)
• Jcr Pharmaceuticals Co. Ltd. (Japan)
• Takeda Pharmaceutical Company Limited (Japan)
• Others Key Player

Key Industry Developments in the Stem Cell Therapy Market 

• April 2024: The Agency for Science, Technology, and Research in Singapore and SCG Cell Therapy (SCG) collaborated to advance the manufacturing of induced pluripotent stem cells (iPSC) that meet good manufacturing practices (GMP) standards.

• June 2023: StemCyte signed a cooperation agreement with a US-based company that develops allogeneic genetically modified CAR-NK cells using umbilical cord blood. Under this agreement, StemCyte has agreed to supply raw materials required for allogeneic cell therapy product development.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Stem Cell Therapy Market by Therapy
 4.1 Stem Cell Therapy Market Snapshot and Growth Engine
 4.2 Stem Cell Therapy Market Overview
 4.3 Autologous Cellular Immunotherapies
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Autologous Cellular Immunotherapies: Geographic Segmentation Analysis
 4.4 Autologous Stem Cell Therapy
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Autologous Stem Cell Therapy: Geographic Segmentation Analysis

Chapter 5: Stem Cell Therapy Market by Source
 5.1 Stem Cell Therapy Market Snapshot and Growth Engine
 5.2 Stem Cell Therapy Market Overview
 5.3 Bone Marrow
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Bone Marrow: Geographic Segmentation Analysis
 5.4 Epidermis
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Epidermis: Geographic Segmentation Analysis
 5.5 Mesenchymal Stem Cells
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Mesenchymal Stem Cells: Geographic Segmentation Analysis
 5.6 Other sources
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Other sources: Geographic Segmentation Analysis

Chapter 6: Stem Cell Therapy Market by Application
 6.1 Stem Cell Therapy Market Snapshot and Growth Engine
 6.2 Stem Cell Therapy Market Overview
 6.3 Cancer
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Cancer: Geographic Segmentation Analysis
 6.4 Cardiovascular Disorders
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Cardiovascular Disorders: Geographic Segmentation Analysis
 6.5 Neurodegenerative Disorders
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Neurodegenerative Disorders: Geographic Segmentation Analysis
 6.6 Orthopedics
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Orthopedics: Geographic Segmentation Analysis
 6.7 Others
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Others: Geographic Segmentation Analysis

Chapter 7: Stem Cell Therapy Market by End Use
 7.1 Stem Cell Therapy Market Snapshot and Growth Engine
 7.2 Stem Cell Therapy Market Overview
 7.3 Hospitals & Clinics
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Hospitals & Clinics: Geographic Segmentation Analysis
 7.4 Ambulatory Surgical Centers
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Ambulatory Surgical Centers: Geographic Segmentation Analysis
 7.5 Research Centers
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Research Centers: Geographic Segmentation Analysis
 7.6 Others
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Others: Geographic Segmentation Analysis

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Benchmarking
  8.1.2 Stem Cell Therapy Market Share by Manufacturer (2023)
  8.1.3 Industry BCG Matrix
  8.1.4 Heat Map Analysis
  8.1.5 Mergers and Acquisitions
  
 8.2 ATHERSYS INC
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Role of the Company in the Market
  8.2.5 Sustainability and Social Responsibility
  8.2.6 Operating Business Segments
  8.2.7 Product Portfolio
  8.2.8 Business Performance
  8.2.9 Key Strategic Moves and Recent Developments
  8.2.10 SWOT Analysis
 8.3 MESOBLAST LTD
 8.4 BIORESTORATIVE THERAPIES INC
 8.5 PLURISTEM INC
 8.6 BRAINSTORM CELL LIMITED
 8.7 VIACYTE INC
 8.8 GAMIDA CELL
 8.9 HOPE BIOSCIENCES
 8.10 CELLULAR BIOMEDICINE GROUP
 8.11 SMITH+NEPHEW
 8.12 MEDIPOST
 8.13 ANTEROGEN C.O
 8.14 LTD
 8.15 NUVASIVE INC
 8.16 RTI SURGICAL
 8.17 ALLOSOURCE
 8.18 JCR PHARMACEUTICALS CO. LTD
 8.19 TAKEDA PHARMACEUTICAL COMPANY LIMITED
 8.20 OTHERS KEY PLAYER

Chapter 9: Global Stem Cell Therapy Market By Region
 9.1 Overview
 9.2. North America Stem Cell Therapy Market
  9.2.1 Key Market Trends, Growth Factors and Opportunities
  9.2.2 Top Key Companies
  9.2.3 Historic and Forecasted Market Size by Segments
  9.2.4 Historic and Forecasted Market Size By Therapy
   9.2.4.1 Autologous Cellular Immunotherapies
   9.2.4.2 Autologous Stem Cell Therapy
  9.2.5 Historic and Forecasted Market Size By Source
   9.2.5.1 Bone Marrow
   9.2.5.2 Epidermis
   9.2.5.3 Mesenchymal Stem Cells
   9.2.5.4 Other sources
  9.2.6 Historic and Forecasted Market Size By Application
   9.2.6.1 Cancer
   9.2.6.2 Cardiovascular Disorders
   9.2.6.3 Neurodegenerative Disorders
   9.2.6.4 Orthopedics
   9.2.6.5 Others
  9.2.7 Historic and Forecasted Market Size By End Use
   9.2.7.1 Hospitals & Clinics
   9.2.7.2 Ambulatory Surgical Centers
   9.2.7.3 Research Centers
   9.2.7.4 Others
  9.2.8 Historic and Forecast Market Size by Country
   9.2.8.1 US
   9.2.8.2 Canada
   9.2.8.3 Mexico
 9.3. Eastern Europe Stem Cell Therapy Market
  9.3.1 Key Market Trends, Growth Factors and Opportunities
  9.3.2 Top Key Companies
  9.3.3 Historic and Forecasted Market Size by Segments
  9.3.4 Historic and Forecasted Market Size By Therapy
   9.3.4.1 Autologous Cellular Immunotherapies
   9.3.4.2 Autologous Stem Cell Therapy
  9.3.5 Historic and Forecasted Market Size By Source
   9.3.5.1 Bone Marrow
   9.3.5.2 Epidermis
   9.3.5.3 Mesenchymal Stem Cells
   9.3.5.4 Other sources
  9.3.6 Historic and Forecasted Market Size By Application
   9.3.6.1 Cancer
   9.3.6.2 Cardiovascular Disorders
   9.3.6.3 Neurodegenerative Disorders
   9.3.6.4 Orthopedics
   9.3.6.5 Others
  9.3.7 Historic and Forecasted Market Size By End Use
   9.3.7.1 Hospitals & Clinics
   9.3.7.2 Ambulatory Surgical Centers
   9.3.7.3 Research Centers
   9.3.7.4 Others
  9.3.8 Historic and Forecast Market Size by Country
   9.3.8.1 Bulgaria
   9.3.8.2 The Czech Republic
   9.3.8.3 Hungary
   9.3.8.4 Poland
   9.3.8.5 Romania
   9.3.8.6 Rest of Eastern Europe
 9.4. Western Europe Stem Cell Therapy Market
  9.4.1 Key Market Trends, Growth Factors and Opportunities
  9.4.2 Top Key Companies
  9.4.3 Historic and Forecasted Market Size by Segments
  9.4.4 Historic and Forecasted Market Size By Therapy
   9.4.4.1 Autologous Cellular Immunotherapies
   9.4.4.2 Autologous Stem Cell Therapy
  9.4.5 Historic and Forecasted Market Size By Source
   9.4.5.1 Bone Marrow
   9.4.5.2 Epidermis
   9.4.5.3 Mesenchymal Stem Cells
   9.4.5.4 Other sources
  9.4.6 Historic and Forecasted Market Size By Application
   9.4.6.1 Cancer
   9.4.6.2 Cardiovascular Disorders
   9.4.6.3 Neurodegenerative Disorders
   9.4.6.4 Orthopedics
   9.4.6.5 Others
  9.4.7 Historic and Forecasted Market Size By End Use
   9.4.7.1 Hospitals & Clinics
   9.4.7.2 Ambulatory Surgical Centers
   9.4.7.3 Research Centers
   9.4.7.4 Others
  9.4.8 Historic and Forecast Market Size by Country
   9.4.8.1 Germany
   9.4.8.2 UK
   9.4.8.3 France
   9.4.8.4 Netherlands
   9.4.8.5 Italy
   9.4.8.6 Russia
   9.4.8.7 Spain
   9.4.8.8 Rest of Western Europe
 9.5. Asia Pacific Stem Cell Therapy Market
  9.5.1 Key Market Trends, Growth Factors and Opportunities
  9.5.2 Top Key Companies
  9.5.3 Historic and Forecasted Market Size by Segments
  9.5.4 Historic and Forecasted Market Size By Therapy
   9.5.4.1 Autologous Cellular Immunotherapies
   9.5.4.2 Autologous Stem Cell Therapy
  9.5.5 Historic and Forecasted Market Size By Source
   9.5.5.1 Bone Marrow
   9.5.5.2 Epidermis
   9.5.5.3 Mesenchymal Stem Cells
   9.5.5.4 Other sources
  9.5.6 Historic and Forecasted Market Size By Application
   9.5.6.1 Cancer
   9.5.6.2 Cardiovascular Disorders
   9.5.6.3 Neurodegenerative Disorders
   9.5.6.4 Orthopedics
   9.5.6.5 Others
  9.5.7 Historic and Forecasted Market Size By End Use
   9.5.7.1 Hospitals & Clinics
   9.5.7.2 Ambulatory Surgical Centers
   9.5.7.3 Research Centers
   9.5.7.4 Others
  9.5.8 Historic and Forecast Market Size by Country
   9.5.8.1 China
   9.5.8.2 India
   9.5.8.3 Japan
   9.5.8.4 South Korea
   9.5.8.5 Malaysia
   9.5.8.6 Thailand
   9.5.8.7 Vietnam
   9.5.8.8 The Philippines
   9.5.8.9 Australia
   9.5.8.10 New Zealand
   9.5.8.11 Rest of APAC
 9.6. Middle East & Africa Stem Cell Therapy Market
  9.6.1 Key Market Trends, Growth Factors and Opportunities
  9.6.2 Top Key Companies
  9.6.3 Historic and Forecasted Market Size by Segments
  9.6.4 Historic and Forecasted Market Size By Therapy
   9.6.4.1 Autologous Cellular Immunotherapies
   9.6.4.2 Autologous Stem Cell Therapy
  9.6.5 Historic and Forecasted Market Size By Source
   9.6.5.1 Bone Marrow
   9.6.5.2 Epidermis
   9.6.5.3 Mesenchymal Stem Cells
   9.6.5.4 Other sources
  9.6.6 Historic and Forecasted Market Size By Application
   9.6.6.1 Cancer
   9.6.6.2 Cardiovascular Disorders
   9.6.6.3 Neurodegenerative Disorders
   9.6.6.4 Orthopedics
   9.6.6.5 Others
  9.6.7 Historic and Forecasted Market Size By End Use
   9.6.7.1 Hospitals & Clinics
   9.6.7.2 Ambulatory Surgical Centers
   9.6.7.3 Research Centers
   9.6.7.4 Others
  9.6.8 Historic and Forecast Market Size by Country
   9.6.8.1 Turkey
   9.6.8.2 Bahrain
   9.6.8.3 Kuwait
   9.6.8.4 Saudi Arabia
   9.6.8.5 Qatar
   9.6.8.6 UAE
   9.6.8.7 Israel
   9.6.8.8 South Africa
 9.7. South America Stem Cell Therapy Market
  9.7.1 Key Market Trends, Growth Factors and Opportunities
  9.7.2 Top Key Companies
  9.7.3 Historic and Forecasted Market Size by Segments
  9.7.4 Historic and Forecasted Market Size By Therapy
   9.7.4.1 Autologous Cellular Immunotherapies
   9.7.4.2 Autologous Stem Cell Therapy
  9.7.5 Historic and Forecasted Market Size By Source
   9.7.5.1 Bone Marrow
   9.7.5.2 Epidermis
   9.7.5.3 Mesenchymal Stem Cells
   9.7.5.4 Other sources
  9.7.6 Historic and Forecasted Market Size By Application
   9.7.6.1 Cancer
   9.7.6.2 Cardiovascular Disorders
   9.7.6.3 Neurodegenerative Disorders
   9.7.6.4 Orthopedics
   9.7.6.5 Others
  9.7.7 Historic and Forecasted Market Size By End Use
   9.7.7.1 Hospitals & Clinics
   9.7.7.2 Ambulatory Surgical Centers
   9.7.7.3 Research Centers
   9.7.7.4 Others
  9.7.8 Historic and Forecast Market Size by Country
   9.7.8.1 Brazil
   9.7.8.2 Argentina
   9.7.8.3 Rest of SA

Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies

Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research